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Summary
 
Secondary lymphoid tissue organogenesis requires tumor necrosis factor (TNF) and lympho-
toxin 
 
a
 
 (LT
 
a
 
). The role of TNF in B cell positioning and formation of follicular structure was
studied by comparing the location of newly produced naive recirculating and antigen-stimu-
 
lated B cells in TNF
 
2
 
/
 
2
 
 and TNF/LT
 
a
 
2
 
/
 
2
 
 mice. By creating radiation bone marrow chimeras
from wild-type and TNF
 
2
 
/
 
2
 
 mice, formation of normal splenic B cell follicles was shown to
depend on TNF production by radiation-sensitive cells of hemopoietic origin. Reciprocal
adoptive transfers of mature B cells between wild-type and knockout mice indicated that nor-
mal follicular tropism of recirculating naive B cells occurs independently of TNF derived from
the recipient spleen. Moreover, soluble TNF receptor–IgG fusion protein administered in vivo
failed to prevent B cell localization to the follicle or the germinal center reaction. Normal T
zone tropism was observed when antigen-stimulated B cells were transferred into TNF
 
2
 
/
 
2
 
recipients, but not into TNF/LT
 
a
 
2
 
/
 
2
 
 recipients. This result appeared to account for the defect
in isotype switching observed in intact TNF/LT
 
a
 
2
 
/
 
2
 
 mice because TNF/LT
 
a
 
2
 
/
 
2
 
 B cells,
when stimulated in vitro, switched isotypes normally. Thus, TNF is necessary for creating the
permissive environment for B cell movement and function, but is not itself responsible for
these processes.
Key words: tumor necrosis factor • lymphotoxin • B cell movement • germinal center • 
follicular structure
he arrangement of lymphocytes into T and B cell
zones within secondary lymphoid tissue is designed to
optimize interactions between these cells (1). Of particular
importance for the shaping of the B cell repertoire are the
events that occur at the interface between the two zones,
which involve three types of B cells. The first comprises
newly generated B cells derived from the bone marrow
competing for selection into the recirculating pool. Al-
though the mechanism remains uncertain, this point of
selection is critical because the number of such B cells ex-
ceeds the number required to maintain homeostasis of the
recirculating repertoire (2–4). The second consists of mature
naive B cells recirculating through follicles. Third, B cells
stimulated by antigen above a critical concentration thresh-
old undergo arrest in the outer periarteriolar lymphoid
sheath (PALS)
 
1
 
 (the T zone), where the chance of cognate
T cell help is optimal (5, 6). If T cell help is provided, the B
cells differentiate into antibody-forming cells, which aggre-
gate within extrafollicular proliferative foci, and intrafollicu-
lar germinal centers (GCs [5, 7]). Conversely, should T cell
help be absent, as occurs in the case of self-reactive B cells,
they die in the outer PALS, leading to tolerance (8, 9).
Mice lacking both membrane-bound and soluble lym-
photoxin (LT)
 
a
 
 exhibit marked disorganization of the
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Abbreviations used in this paper:
 
 BLR1, Burkitt lymphoma receptor 1;
CFSE, 5-(and -6-)-carboxyfluorescein diacetate succinimidyl ester; FDC,
follicular dendritic cell; GC, germinal center; HEL, hen egg lysozyme;
LT, lymphotoxin; PALS, periarteriolar lymphoid sheath; PNA, peanut
agglutinin; Tg, transgenic; TNFR-Ig, TNFR-1–IgG fusion protein; WT,
wild-type.
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B Cell Movement Is Independent of TNF
 
splenic white pulp, and fail to form either LNs or Peyer’s
patches (10, 11). An even more striking defect has been
observed in the spleens from mice with combined deficien-
cies of TNF and LT
 
a
 
 in which virtually no microarchitec-
tural B or T cell aggregation takes place (12, 13). By con-
trast, LNs do develop in TNF
 
2
 
/
 
2
 
 and TNFR-1
 
2
 
/
 
2
 
 (p55)
mice, but the microarchitecture of their LNs and splenic
white pulp is abnormal (13, 14). Members of the TNF and
TNFR families also contribute to the events underlying
antigen-induced B cell activation and differentiation. Thus,
splenic GCs fail to develop in mice lacking either LT
 
a
 
,
LT
 
b
 
, TNF, or TNFR-1 (13–17). Although TNF and LT
are critical for normal lymphoid organogenesis, the mecha-
nism whereby they signal the specific migration of lympho-
cyte subsets remains uncertain. In this paper, the role of
TNF compared with LT in regulating movement and posi-
tioning of naive and antigen-activated B cells has been in-
vestigated in a unique set of inbred C57BL/6-TNF
 
2
 
/
 
2
 
 and
TNF/LT
 
a
 
2
 
/
 
2
 
 mice. The results indicate that TNF derived
from a hemopoietic precursor plays a crucial role in devel-
opment of splenic white pulp, including the T–B interface,
but is not itself responsible for correct B cell movement and
function within the follicle.
 
Materials and Methods
 
Mice.
 
TNF
 
2
 
/
 
2
 
 and TNF/LT
 
a
 
2
 
/
 
2
 
 mice were generated using
C57BL/6 embryonic stem cells, as described previously (13, 18).
Ig transgenic (Tg) B cells were obtained from anti–hen egg
lysozyme (HEL) Tg mice (MD4 line [19]). All three lines were
established and maintained on an inbred C57BL/6 background.
Wild-type (WT) C57BL/6 and C57BL/6-Ly5.1 congenic mice
were obtained from the Animal Resources Centre (Perth, Austra-
lia). Mice were bred and housed under specific pathogen–free
conditions in the animal facility of the Centenary Institute, Syd-
ney. All animal procedures were approved by the Animal Care
and Ethics Committee, University of Sydney.
 
Antibodies and Reagents.
 
The following reagents were used—
mAbs: rat anti–mouse B220 (RA3.6B2, PE-conjugate; PharMin-
gen, San Diego, CA), rat anti–mouse CD4 (RM4-4; PharMingen),
rat anti–mouse CD8 (53-6.7; PharMingen), rat anti–mouse CD11b
(Mac-1, M1/70; PharMingen), and rat anti-IgE mAbs (R1E4 and
B1E3 [20]); specific polyclonal antisera: rabbit anti–hen egg
lysozyme (HEL), rabbit IgG anti–Burkitt lymphoma receptor 1
(BLR1 [21]), and anti-IgM and -IgG subclasses (Southern Biotech-
nology Associates, Inc., Birmingham, AL); control antibodies: rat
IgG2a (PharMingen), biotinylated rat IgG2b (PharMingen), and
purified rabbit IgG (Vector Laboratories, Inc., Burlingame, CA);
conjugates: goat anti–rat Texas Red (Caltag Laboratories, Inc.,
Burlingame, CA), goat F(ab
 
9
 
)
 
2
 
 anti–rabbit FITC (Silenus, Mel-
bourne, Australia), rabbit anti–rat horseradish peroxidase (DAKO
Pty. Ltd., Botany, NSW, Australia), avidin-FITC (Molecular
Probes, Inc., Eugene, OR), avidin-fluoroblue (Biomedia, Foster
City, CA), streptavidin–alkaline phosphatase (DAKO Pty. Ltd.),
and peanut agglutinin (PNA)-biotin and PNA-FITC (Vector Lab-
oratories, Inc.). The substrate for alkaline phosphatase was a mix-
ture of 5-bromo-4-chloro-3-indoxyl phosphate (BCIP; Diagnostic
Chemicals Ltd., Charlottetown, Prince Edward Island, Canada)
and nitro-blue tetrazolium (NBT; Sigma Chemical Co., St. Louis,
MO). Horseradish peroxidase–labeled secondary antibodies were
developed with diaminobenzidine (DAB; Sigma Chemical Co.).
 
TNFR-1–IgG1 fusion protein (TNFR-Ig) consisted of a
dimeric human 
 
g
 
1 heavy chain fused to human TNFR-1 (p55;
reference 22). The efficacy of in vivo TNF blockade by TNFR-
Ig was confirmed by giving groups of WT mice a single injection
of 200 
 
m
 
g TNFR-Ig or PBS, followed 21 h later by a lethal com-
bination of 100 
 
m
 
g LPS and 20 mg 
 
d
 
-galactosamine. Mice receiv-
ing TNFR-Ig showed no effects of endotoxic shock and sur-
vived. Untreated mice were dead within 8.5 h (data not shown).
Moreover, others have shown (23–25) that administration of
TNFR-Ig or LT
 
b
 
R-Ig to adult mice at doses comparable to that
used in the present studies (
 
a
 
) affects lymphoid tissue neogenesis
and microarchitecture in the developing fetus as well as subse-
quent GC formation in the offspring (TNFR-Ig and LT
 
b
 
R-Ig),
and (
 
b
 
) prevents GC formation in the adult mouse itself (LT
 
b
 
R).
 
Animal Manipulations.
 
B cells were prepared, 5-(and -6-)-car-
boxyfluorescein diacetate succinimidyl ester (CFSE) labeled, and
transferred as described previously (5). For induction of T cell–
dependent B cell responses in vivo, mice were immunized with
200 
 
m
 
l i.p. of SRBC (10% vol/vol; provided by Dr. D. Emory,
Commonwealth Scientific and Industrial Research Organization,
Sydney, Australia). Radiation bone marrow chimeras were gener-
ated as described previously (26). In brief, 2 
 
3 
 
10
 
7
 
 bone marrow
cells from C57BL/6-TNF
 
2
 
/
 
2
 
 (Ly5.2) donors (TNF
 
2
 
/
 
2
 
®
 
WT)
were injected into C57BL/6-Ly5.1 congenic recipients that had
been irradiated (5.5 Gy-
 
g
 
) on days 
 
2
 
2 and 0 and vice versa
(WT
 
®
 
TNF
 
2
 
/
 
2
 
). 16 wk after reconstitution, 
 
.
 
95% chimerism
was confirmed by FACS
 
Ò
 
 analysis of Ly5.1 expression by PB-
MCs. The mice were used 30 wk after chimera establishment.
 
Immunohistology.
 
Fluorescence immunohistology and immu-
nocytochemistry were performed on frozen sections, as described
previously (5). Immunohistochemistry double staining was devel-
oped using alkaline phosphatase substrate (BCIP/NBT) followed
by the horseradish peroxidase substrate DAB. After the final
wash, slides were mounted and examined by standard bright-field
or epifluorescence microscopy (Leitz DMR BE; Leica AG, St.
Gallen, Switzerland).
 
Flow Cytometry.
 
Cells were maintained on ice throughout all
labeling procedures. 2–5 
 
3 
 
10
 
5
 
 aliquots of cells were examined
by flow cytometry using a FACScan
 
Ò
 
 
 
(Becton Dickinson, San
Jose, CA). Data were analyzed with CellQuest software.
 
B Cell Proliferation and Ig Production In Vitro.
 
Small dense B cells
were prepared from mouse spleen as described previously (27)
except for the additional use of anti-CD8 (31M) in T cell deple-
tion. B cells (5 
 
3 
 
10
 
5
 
/ml) were incubated in 100 
 
m
 
l B cell
medium (RPMI 1640 supplemented with 10% FCS [Trace Bio-
sciences Pty. Ltd., Castle Hill, NSW, Australia]) and combina-
tions of T cell membrane (27), recombinant IL-4, membrane
from baculovirus-infected Sf9 cells expressing mouse CD40L
(baculo-CD40L [28]), LPS (
 
Salmonella typhosa
 
; Sigma Chemical
Co.), and mitogenic anti-IgM (b7.6) and anti-IgD (1.19). Cul-
tures were incubated for 3 d, then pulsed with [
 
3
 
H]thymidine
(ICN Biomedicals, Inc., Costa Mesa, CA) for 4 h before harvest-
ing and measurement of proliferation by scintillation counting.
Triplicate cultures containing baculo-CD40L and IL-4 were in-
cubated for 7 d before supernatant was harvested for measure-
ment of total IgM, IgG1, or IgE by ELISA.
 
Results and Discussion
 
TNF from a Bone Marrow–derived Cell Controls Follicular
Tropism of Naive Bone Marrow Emigrants.
 
Data from our own
and other groups point to a role for TNF (and LT
 
a
 
) in es-
tablishment of B cell follicles. In TNF
 
2
 
/
 
2
 
 mice, B cells are 
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arranged in rim-like structures around the T cell aggre-
gates, and segregation of red and white pulp as well as the
interface between T and B cell zones is poorly preserved
(13, 14; Fig. 1, 
 
A
 
–
 
D
 
). In TNF/LT
 
a
 
2
 
/
 
2
 
 mice, the lym-
phoid aggregates (white pulp) are poorly organized, dimin-
ished in size, and overlapping so that clear demarcation be-
tween T and B cell zones is lost and there is a relative
increase in proportion of lymphocytes within the red pulp
(references 12, 13, and data not shown). To clarify the role
of TNF in these changes, bone marrow chimeras were cre-
ated by reconstituting WT animals with TNF
 
2
 
/
 
2
 
 bone
marrow and vice versa. The white pulp morphology of
WT recipients of TNF
 
2
 
/
 
2
 
 bone marrow (Fig. 1, 
 
E
 
 and 
 
F
 
)
had acquired the features of TNF
 
2
 
/
 
2
 
 mice, including a loss
of distinct follicles and a blurred T–B cell interface. By
contrast, the TNF
 
2
 
/
 
2
 
 recipients of WT bone marrow (Fig.
1, 
 
H
 
 and 
 
I
 
) resembled WT mice. A cohort of bone marrow
chimeras were immunized with SRBC. Spleens from these
mice revealed well-defined PNA
 
1
 
 GCs within the follicles
of TNF
 
2
 
/
 
2
 
 recipients of WT bone marrow (Fig. 1 J),
whereas most B cell aggregates in TNF2/2®WT bone
marrow chimeras showed no evidence of GC formation
(Fig. 1 G).
Thus, TNF derived predominantly from hemopoietic
precursors rather than radiation-resistant stromal elements
is needed for the development of a normal white pulp ca-
pable of supporting subsequent antigen-dependent events
within it, including GC formation. Experiments with LTa2/2
bone marrow have yielded comparable results (29). Inter-
estingly, the LTa2/2®WT bone marrow reconstitution
was shown to result in the loss of follicular dendritic cells
(FDCs) and GCs but preservation of the demarcation be-
tween T and B cell zones (29), which points to an exclu-
sive role for TNF in this latter feature of splenic organiza-
tion. The results reported here complement the work of
Tkachuk et al. (30) in TNFR-12/2 chimeric mice, indicat-
ing a requirement for TNFR-1 expression on nonhe-
mopoietic cells in maintenance of splenic architecture and
B cell location.
GC Reactions Are Not Dependent on TNF-mediated Signals.
There are two explanations for the dependence of GC for-
mation on TNFR-1 ligation. First TNFR-1 ligation may
be required during the cellular interactions after exposure
to antigen. Alternatively, it may act during organogenesis
to create a permissive environment for later development
of GC reactions. To distinguish between these two pos-
sibilities, WT mice were immunized with SRBC (day 0)
and treated with TNFR-Ig (which binds TNF and soluble
LTa3 [22]) on three occasions from day 2 after immu-
nization until 1 d before killing and analysis of GC devel-
opment. Despite TNF blockade in treated mice, GC
reactions had developed normally on day 7 and were indis-
tinguishable from those observed in WT mice treated with
PBS (data not shown, but see also reference 25). Further-
more, GCs in the spleens of both types of mice contained
organized clusters of FDCs (data not shown). Therefore,
TNF-mediated interactions act during development of lym-
phoid structure to create a milieu wherein GC reactions
can then proceed, rather than being involved in the cellular
interactions responsible for GC formation per se. One ca-
veat is that TNFR-Ig may not completely block the
TNFR-1 signals necessary for GC formation in vivo. How-
ever, our own and others’ experience argues against this
possibility (see Materials and Methods).
Follicular Tropism of Mature Recirculating B Cells Is Depen-
dent on Follicular Composition, not Direct TNF or LTa Signal-
ing. Mature recirculating B cells rapidly enter the follicles
after adoptive transfer into nonirradiated WT mice (5, 6).
To determine whether the absence of TNF or TNF/LTa
perturbs this process, mature naive splenic B cells from WT
or TNF2/2 donors were labeled with CFSE and transferred
into either WT, TNF2/2, or TNF/LTa2/2 recipients.
The vast majority of WT donor cells were located within
WT follicles 24 h after transfer (Fig. 2 A). By contrast, fol-
licular homing was compromised particularly in TNF/
LTa2/2 recipients, presumably due to disruption of archi-
tecture of the follicle (Fig. 2 C). In TNF2/2 recipients, B
cells from either WT or TNF2/2 donors were largely lo-
cated in the vicinity of the follicles which were better pre-
served than in mice lacking both cytokine genes (Fig. 2, B
and D). When the experiment was reversed and B cells
from either TNF2/2 or TNF/LTa2/2 donors were trans-
ferred into WT recipients, precise B cell migration to the
follicles was observed (Fig. 2, E and F).
These results suggest that TNF plays a role in generation
of normal white pulp but does not directly influence hom-
ing of naive B cells. To explore this further, naive B cell
migration was examined after administration of TNFR-Ig.
On this occasion, anti-HEL Ig Tg mice were used as do-
nors, enabling tracking of B cells by virtue of HEL binding
to the transgene-encoded surface Ig (follicular tropism of
naive Ig Tg B cells was shown previously to be identical to
that of non-Tg B cells [5]). WT recipients were injected
with either 200 mg i.v. TNFR-Ig or PBS 4 h before Ig Tg
B cell transfer. 20 h later, the distribution of HEL-binding
B cells in both TNFR-Ig–treated recipients and PBS-
treated controls was identical (Fig. 2, G and H), demon-
strating precise localization to the B cell follicles consistent
with findings obtained in previous transfer experiments.
Expression of the BLR1 Chemokine Receptor Is Maintained
in the Absence of TNF and LTa. Once the follicles were
established, B cell follicular tropism did not require TNF
(Fig. 2 D) or LTa3 (Fig. 2, G and H). This made good
sense, particularly given the ubiquitous expression of TNF
and the need for a highly focused mechanism to direct in-
trafollicular B cell traffic. Nevertheless, the necessity for
TNF in the recipient follicle suggested that B cell follicular
tropism is mediated by a TNF-dependent factor. One at-
tractive candidate was the chemokine receptor BLR1 be-
cause it is expressed on naive but not activated B cells (31)
and the splenic white pulp of BLR12/2 mice resembles
that of TNF2/2 and TNFR-12/2 mice (31). Moreover,
splenic follicular tropism of recirculating BLR12/2 B cells
was shown to be perturbed, whereas migration of WT B
cells into the B cell zones of BLR12/2 recipients was nor-
mal. To examine the role of BLR1, spleen cells were ob-1506 B Cell Movement Is Independent of TNF
Figure 1. WT bone marrow restores correct follic-
ular structure and GC reaction in lethally irradiated
TNF2/2 recipients. (A–D) Spleen sections from un-
manipulated 6–10-wk-old animals were stained for a
combination of CD41 and CD81 T cells (brown) and
B2201 B cells (blue). (E–J) TNF2/2 bone marrow
was injected into lethally irradiated WT recipients
(E–G) and WT bone marrow into TNF2/2 recipients
(H–J). 30 wk later, spleen sections were stained by
immunohistochemistry for CD41 and CD81 T cells
(brown) and B2201 B cells (blue) (E, F, H, and I), or
sections obtained 8 d after immunization with SRBC
were stained for B cells (red) and PNA1 GCs (blue/
purple) (G and J). Arrows, Central arterioles; arrow-
heads, T–B interface. Bar 5 400 mm (A and C), 200
mm (E, G, H, and J), or 100 mm (B, D, F, and I).
tained from WT, TNF2/2, and TNF/LTa2/2 mice, and
BLR1 expression was assessed by flow cytometry. Dual
staining of WT spleen cells for a range of phenotype mark-
ers revealed that 95% of B2201 cells expressed BLR1,
whereas  ,3% of CD41, CD81, or Mac-11 cells were pos-
itive (data not shown). When BLR1 expression on WT
B220 cells was compared with that on the same cells from
TNF2/2 or TNF/LTa2/2 mice, not only were levels1507 Cook et al.
maintained in the absence of TNF and LTa, but they also
showed a consistent albeit small increase above the control
(Fig. 3). Thus, although a role for BLR1 in mediating the
effects of TNF (and LT) on primary B cell follicular struc-
ture was excluded, the increase in level of expression is
consistent with reduced receptor internalization, possibly
secondary to a deficit in its recently described ligand, BLC
(32).
Figure 2. Localization of B cells is
determined by the splenic environ-
ment. (A–E) Purified, CFSE-labeled B
cells from WT and mutant mice were
transferred into WT, TNF2/2, and
TNF/LTa2/2 recipients in combina-
tions as indicated. (G and H) Anti–
HEL-Ig Tg B cells were transferred at
day 0 intravenously to WT recipients
immediately after intraperitoneal in-
jection of 0.5 ml PBS (control) or 200
mg TNFR-Ig in 0.5 ml PBS. Spleen
sections were stained 20 h after cell
transfer for splenic B cells (red) and
transferred B cells (CSFE or HEL-spe-
cific Ig; yellow). Bar 5 200 mm.1508 B Cell Movement Is Independent of TNF
Migration of Antigen-stimulated B Cells Is Preserved in
TNF2/2 but not TNF/LTa2/2 Mice. To follow the phys-
iological migration of B cells to the T zone after antigen li-
gation of the B cell antigen receptor (5, 8), HEL-specific Ig
Tg B cells (TNF and LTa–positive) were stimulated in
vitro with 100 ng/ml HEL, and then injected into WT,
TNF2/2, or TNF/LTa2/2 recipients, where they were
detected in the spleen using HEL-specific antiserum. In
WT mice, B cells migrated to the outer PALS, where they
remained for at least 24 h (Fig. 4 A). Similarly, when acti-
vated Ig Tg B cells were transferred into TNF2/2 recipi-
ents, they arrested precisely in the outer PALS (Fig. 4 B).
However, antigenic stimulation had no apparent influence
on the migration pattern of B cells transferred into TNF/
LTa2/2 recipients. Thus, B cells were distributed ran-
domly throughout the red and white pulp of the recipients
(Fig. 4 C), as had been observed previously after transfer of
naive B cells into TNF/LTa2/2 recipients (Fig. 2 C).
T Cell–dependent B Cell Stimulation In Vitro Is Independent
of TNF or LTa. T cell–dependent B cell responses are
grossly impaired in TNF/LTa2/2 mice, whereas only some
aspects are deficient in the absence of TNF (13, 14). To in-
vestigate the possibility that the absence of TNF and/or LT
from B cells prevents B cell proliferation and differentiation,
purified small resting B cells were prepared from the spleens
of both TNF2/2 and TNF/LTa2/2 mice and stimulated in
vitro using protocols that reproduce T cell–dependent and
–independent activation. Stimulation with either activated
T cell membranes or recombinant CD40L resulted in com-
parable proliferation of B cells irrespective of whether they
were obtained from TNF2/2, TNF/LTa2/2, or WT mice.
In each case, proliferation was enhanced by the addition of
IL-4 (Fig. 5 A). Similarly, production of IgM, IgG1, and
IgE by B cells from both mutant strains was normal in the
presence of IL-4 (Fig. 5 B). T cell–independent B cell acti-
vation with anti-IgM, anti-IgD, or LPS was also unaffected
by either mutation (data not shown).
The preceding experiments indicate that the failure of
isotype switching in TNF/LTa2/2 mice is due to loss of T
Figure 3. BLR1 expression is maintained in the absence of TNF and
LT. Spleen cells from WT C57BL/6, TNF2/2, and TNF/LTa2/2 mice
were dual labeled for B cells (PE anti-B220 mAb) and with either rabbit
anti-BLR1 or as a control, rabbit IgG (10 mg/ml) followed by FITC anti–
rabbit IgG. Histograms, BLR1 expression of B2201 cells. Dotted line, Rab-
bit IgG background staining of WT B2201 cells. Background staining of
B cells from TNF2/2 and TNF/LTa2/2 mice was comparable to that of
WT mice. Spleen cells derived from groups of three mice were examined
individually, and similar results were obtained for each.
Figure 4. Activated B cells migrate normally to the outer PALS in TNF2/2 mice. Splenic HEL-Ig Tg B cells were isolated and stimulated in vitro for
60 min with 100 ng/ml HEL. Cells were washed and transferred intravenously into WT, TNF2/2, and TNF/LTa2/2 recipients. Spleen sections were
analyzed 20 h later by staining for B cells (red) and activated HEL-specific Ig Tg B cells (green/yellow). Bar 5 200 mm.
Figure 5. B cell proliferation and Ig production after stimulation in
vitro. Small dense B cells were prepared from the spleens of WT, TNF2/2,
and TNF/LTa2/2 mice and incubated in vitro with baculo-CD40L and
varying doses of IL-4. (A) After 3 d, cell proliferation was measured by
[3H]thymidine incorporation. (B) B cells were incubated for 7 d with bac-
ulo-CD40L and 100 U/ml IL-4. Concentrations of secreted IgM, IgG1,
and IgE in the supernatant were measured by ELISA. Histograms in A
and B depict mean 6 1 SD of triplicate determinations and are represen-
tative of two independent experiments.1509 Cook et al.
zone tropism by antigen-stimulated B cells in these mice
(Fig. 4 C) rather than to an intrinsic defect in the switching
mechanism imposed by the absence of these cytokines (Fig.
5). In contrast, the initial phase of the T cell–dependent re-
sponse to antigen is normal in TNF2/2 mice, even though
GCs do not develop. The most likely explanation for this is
the absence of an organized network of FDCs within the B
cell areas. FDC networks have been reported to be absent
not only from TNF2/2 (13, 14), TNF/LTa2/2 (12, 13),
and TNFR-12/2 (15, 16, 30) mice but also from LTa2/2
mice (16). On the other hand, TNF does not appear to be
essential for production of FDCs per se, since TNF2/2
mice contain isolated FDCs (13). Interestingly, the source
of LTa required for formation of FDC networks has been
shown to be the B cell itself, not the T cell (33, 34). Col-
lectively, these findings raise the question of the respective
roles played by TNF and LTa in formation of FDC net-
works and subsequently GC reactions. One possible sce-
nario is that TNF secreted by a cell of hemopoietic origin
interacts with TNFR-11 nonhemopoietic cells, leading to
release of the chemokine BLC. This chemokine could then
bind to BLR1 on adjacent B cells, leading to both forma-
tion of structurally correct follicles (permissive for FDC
clustering) and induction of LT expression on B cells,
which in turn would facilitate development of FDC net-
works. The chimera experiments reported here support
such a scenario. When LTa was available but TNF was not
(TNF2/2®WT), the extent of the GC reaction was signif-
icantly impaired compared with that seen in the presence
of TNF (WT®TNF2/2). That is, the environment was
not permissive for FDC clustering because it had been
formed in the absence of TNF. By contrast, after immuni-
zation, GCs developed normally after administration of
TNFR-Ig to (TNF1/1) WT mice with structurally permis-
sive B cell follicles. TNFR-Ig inhibits the activity of solu-
ble LTa3 as well as TNF (22), but the functionally impor-
tant form of B cell–produced LT for FDC clustering
appears to be the membrane-bound LTa1b2 heterotrimer
(33), which would have escaped neutralization by TNFR-
Ig. Consistent with this is the absence of splenic GCs in
LTb2/2 mice (17) despite secretion of soluble LTa3.
The authors thank D. Godfrey, P. Lalor, B. Scallon, G. Klaus, M. Kehry, B. Castle, H. Briscoe, D. Tarlin-
ton, and B. Fazekas de St. Groth for generously sharing reagents. We appreciate the assistance of Karen
Knight, James Croser, J. Webster, D. Strickland, and Danielle Avery.
This work was funded by a grant from the National Multiple Sclerosis Society of Australia (to H. Körner and
J.D. Sedgwick), a National Health and Medical Research Council Program Grant (to A. Basten and J.D.
Sedgwick), a University of Sydney Medical Foundation Program Grant (to P.D. Hodgkin) and postgraduate
Scholarship (to M.C. Cook), a National Health and Medical Research Council postgraduate Scholarship (to
D.S. Riminton), and a Wellcome Trust Senior Research Fellowship in Australia (to J.D. Sedgwick, held
1992–1996).
Address correspondence to Antony Basten or Jonathon D. Sedgwick, Centenary Institute of Cancer Medi-
cine and Cell Biology, Bldg. 93, Royal Prince Alfred Hospital, Missenden Rd., Camperdown, Sydney,
NSW 2050 Australia. Phone: 61-2-9565-6155; Fax: 61-2-9565-6105; E-mail: a.basten@centenary.
usyd.edu.au or j.sedgwick@centenary.usyd.edu.au 
M.C. Cook’s present address is Department of Immunology, University of Birmingham, Medical School,
Edgbaston, Birmingham, B15 2TT, UK. H. Körner’s present address is Institute for Microbiology, Hygiene
and Immunology, Wasserturmstrasse 3, D-91054 Erlangen, Germany.
Received for publication 13 May 1998 and in revised form 14 August 1998.
References
1. Liu, Y.-J. 1997. Sites of B lymphocyte selection, activation,
and tolerance in spleen. J. Exp. Med. 186:625–629.
2. Lortan, J.E., C.A. Roobottom, S. Oldfield, and I.C.M. Mac-
Lennan. 1987. Newly produced virgin B cells migrate to sec-
ondary lymphoid organs but their capacity to enter follicles is
restricted. Eur. J. Immunol. 17:1311–1316.
3. Gray, D. 1988. Population kinetics of rat peripheral B cells. J.
Exp. Med. 167:805–816.
4. Cyster, J.G. 1997. Signaling thresholds and interclonal com-
petition in pre-immune B-cell selection. Immunol. Rev. 156:
87–101.
5. Cook, M.C., A. Basten, and B. Fazekas de St. Groth. 1997.
Outer periarteriolar lymphoid sheath arrest and subsequent
differentiation of both naive and tolerant immunoglobulin
transgenic B cells is determined by receptor occupancy. J.
Exp. Med. 186:631–643.
6. Cyster, J., and C.C. Goodnow. 1995. Antigen-induced exclu-
sion from follicles and anergy are separate and complemen-
tary processes that influence peripheral B cell fate. Immunity.
3:691–701.
7. Liu, Y.J., J. Zhang, P.J. Lane, E.Y. Chan, and I.C.M. Mac-
Lennan. 1991. Sites of specific B cell activation in primary
and secondary responses to T cell-dependent and T cell-
independent antigens. Eur. J. Immunol. 21:2951–2962.1510 B Cell Movement Is Independent of TNF
8. Cyster, J.G., S.B. Hartley, and C.C. Goodnow. 1994. Com-
petition for follicular niches excludes self-reactive cells from
the recirculating B-cell repertoire. Nature. 371:389–395.
9. Fulcher, D.A., A.B. Lyons, S.L. Korn, M.C. Cook, C. Kol-
erda, C. Parish, B. Fazekas de St. Groth, and A. Basten. 1996.
The fate of self-reactive B cells depends primarily on the de-
gree of antigen receptor engagement and the availability of T
cell help. J. Exp. Med. 183:2313–2328.
10. De Togni, P., J. Goellner, N.H. Ruddle, P.R. Streeter, A.
Fick, S. Mariathasan, S.C. Smith, R. Carlson, L.P. Shornick,
J. Strauss-Schoenberger, et al. 1994. Abnormal development
of peripheral lymphoid organs in mice deficient in lympho-
toxin. Science. 264:703–707.
11. Banks, T.A., B.T. Rouse, M.K. Kerley, P.J. Blair, V.L. God-
frey, N.A. Kuklin, D.M. Bouley, J. Thomas, S. Kanangat,
and M.L. Mucenski. 1995. Lymphotoxin-a-deficient mice:
effects on secondary lymphoid organ development and hu-
moral immune responsiveness. J. Immunol. 155:1685–1693.
12. Eugster, H.-P., M. Müller, U. Karrer, B.D. Car, B. Schny-
der, V.M. Eng, G. Woerly, M. Le Hir, F. di Padova, M. Au-
get, et al. 1996. Multiple immune abnormalities in tumor ne-
crosis factor and lymphotoxin a double-deficient mice. Int.
Immunol. 8:23–36.
13. Körner, H., M. Cook, D.S. Riminton, F.A. Lemckert, R.M.
Hoek, B. Ledermann, F. Köntgen, B. Fazekas de St. Groth,
and J.D. Sedgwick. 1997. Distinct roles for lymphotoxin-a
and tumor necrosis factor in organogenesis and spatial organi-
zation of lymphoid tissue. Eur. J. Immunol. 27:2600–2609.
14. Pasparakis, M., L. Alexopoulou, V. Episkopou, and G. Kollias.
1996. Immune and inflammatory responses in TNF-a–defi-
cient mice: a critical requirement for TNF-a in the for-
mation of primary B cell follicles, follicular dendritic cell
networks and germinal centers, and in the maturation of the
humoral immune response. J. Exp. Med. 184:1397–1411.
15. Le Hir, M., H. Blüthmann, M.H. Kosco-Vilbois, M. Müller,
F. di Padova, M. Moore, B. Ryffel, and H.P. Eugster. 1996.
Differentiation of follicular dendritic cells and full antibody
responses require tumor necrosis factor receptor-1 signaling.
J. Exp. Med. 183:2367–2372.
16. Matsumoto, M., S. Mariathasan, M.H. Nahm, F. Baranyay,
J.J. Peschon, and D.D. Chaplin. 1996. Role of lymphotoxin
and the type I TNF receptor in the formation of germinal
centres. Science. 271:1289–1291.
17. Koni, P.A., R. Sacca, P. Lawton, J.L. Browning, N.H. Rud-
dle, and R.A. Flavell. 1997. Distinct roles in lymphoid or-
ganogenesis for lymphotoxins a and b revealed in lympho-
toxin b-deficient mice. Immunity. 6:491–500.
18. Lemckert, F.A., J.D. Sedgwick, and H. Körner. 1997. Gene
targeting in C57BL/6 ES cells. Successful germ line transmis-
sion using recipient BALB/c blastocysts developmentally ma-
tured in vitro. Nucleic Acids Res. 25:917–918.
19. Goodnow, C.C., J. Crosbie, S. Adelstein, T.B. Lavoie, S.J.
Smith-Gill, R.A. Brink, H. Pritchard-Briscoe, J.S. Wother-
spoon, R.H. Loblay, K. Raphael, et al. 1988. Altered immu-
noglobulin expression and functional silencing of self-reactive
B lymphocytes in transgenic mice. Nature. 334:676–682.
20. Keegan, A.D., C. Fratazzi, B. Shopes, B. Baird, and D.H.
Conrad. 1991. Characterization of new rat anti-mouse IgE
monoclonals and their use along with chimeric IgE to further
define the site that interacts with Fc epsilon RII and Fc epsi-
lon RI. Mol. Immunol. 28:1149–1154.
21. Schmidt, K.N., C.W. Hsu, C.T. Griffin, C.C. Goodnow,
and J.G. Cyster. 1998. Spontaneous follicular exclusion of
SHP1-deficient B cells is conditional on the presence of
competitor wild-type B cells. J. Exp. Med. 187:929–937.
22. Scallon, B.J., H. Trinh, M. Nedelmann, F.M. Brennan, M.
Feldmann, and J. Ghrayeb. 1995. Functional comparisons of
different tumour necrosis factor receptor/IgG fusion proteins.
Cytokine. 7:759–767.
23. Rennert, P.D., J.L. Browning, R. Mebius, F. Mackay, and
P.S. Hochman. 1996. Surface lymphotoxin a/b complex is
required for the development of peripheral lymphoid organs.
J. Exp. Med. 184:1999–2006.
24. Rennert, P.D., J.L. Browning, and P.S. Hochman. 1997. Se-
lective disruption of lymphotoxin ligands reveals a novel set
of mucosal lymph nodes and unique effects on lymph node
cellular organization. Int. Immunol. 9:1627–1639.
25. Mackay, F., G.R. Majeau, P. Lawton, P.S. Hochman, and
J.L. Browning. 1997. Lymphotoxin but not tumor necrosis
factor functions to maintain splenic architecture and humoral
responsiveness in adult mice. Eur. J. Immunol. 27:2033–2042.
26. Riminton, D.S., H. Körner, D.H. Strickland, F.A. Lemckert,
J.D. Pollard, and J.D. Sedgwick. 1998. Challenging cytokine
redundancy: inflammatory cell movement and clinical course
of experimental autoimmune encephalomyelitis are normal in
lymphotoxin-deficient but not TNF-deficient mice. J. Exp.
Med. 187:1517–1528.
27. Hodgkin, P.D., L.C. Yamashita, R.L. Coffman, and M.R.
Kehry. 1990. Separation of events mediating B cell prolifera-
tion and Ig production by using T cell membranes and lym-
phokines. J. Immunol. 145:2025–2034.
28. Kehry, M.R., and B.E. Castle. 1994. Regulation of CD40
ligand expression and use of recombinant CD40 ligand for
studying B cell growth and differentiation. Semin. Immunol. 6:
287–294.
29. Matsumoto, M., S.F. Lo, C.J. Carruthers, J. Min, S. Maria-
thasan, G. Huang, D.R. Plas, S.M. Martin, R.S. Geha, M.H.
Nahm, and D.D. Chaplin. 1996. Affinity maturation without
germinal centres in lymphotoxin-alpha-deficient mice. Na-
ture. 382:462–466.
30. Tkachuk, M., S. Bolliger, B. Ryffel, G. Pluschke, T.A.
Banks, S. Herren, R.H. Gisler, and M.H. Kosco-Vilbois.
1998. Crucial role of tumor necrosis factor receptor 1 expres-
sion on nonhematopoietic cells for B cell localization within
the splenic white pulp. J. Exp. Med. 187:469–477.
31. Förster, R., A.E. Mattis, E. Kremmer, E. Wolf, G. Brem, and
M. Lipp. 1996. A putative chemokine receptor, BLR1, di-
rects B cell migration to defined lymphoid organs and specific
anatomic compartments of the spleen. Cell. 87:1037–1047.
32. Gunn, M.D., V.N. Ngo, K.M. Ansel, E.H. Ekland, J.G. Cys-
ter, and L.T. Williams. 1998. A B-cell homing chemokine
made in lymphoid follicles activates Burkitt’s lymphoma re-
ceptor-1. Nature. 391:799–803.
33. Fu, Y.X., G. Huang, Y. Wang, and D.D. Chaplin. 1998. B
lymphocytes induce the formation of follicular dendritic cell
clusters in a lymphotoxin a–dependent fashion. J. Exp. Med.
187:1009–1018.
34. Gonzalez, M., F. Mackay, J.L. Browning, M.H. Kosco-Vil-
bois, and R.J. Noelle. 1998. The sequential role of lympho-
toxin and B cells in the development of splenic follicles. J.
Exp. Med. 187:997–1007.